Nadroparina

Records for this ingredient, by country (identity only).

ATC B01AB06 · 2 markets · 17 records

Nadroparina 2 markets · 17 records Forms
Filters
MarketFR 8

FR 8 records · 8 shown of 8 Source Base de données publique des médic · Data as of 2026-11-03

  • 19,000 IU per mL / per unit basis not statedinjectionFRAXODI 19 000 U.I. Axa/1 ml, solution injectable (S.C.) en seringue pré-remplie
  • 15,200 IU per mL / per unit basis not statedinjectionFRAXODI 15 200 U.I. Axa/0,8 ml, solution injectable (S.C.) en seringue pré-remplie
  • 11,400 IU per mL / per unit basis not statedinjectionFRAXODI 11 400 U.I. Axa/0,6 ml, solution injectable (S.C.) en seringue pré-remplie
  • 9,500 IU per mL / per unit basis not statedinjectionFRAXIPARINE 9 500 U.I. Axa/1 ml, solution injectable (S.C.) en seringue pré-remplie
  • 7,600 IU per mL / per unit basis not statedinjectionFRAXIPARINE 7 600 U.I. Axa/0,8 ml, solution injectable (S.C.) en seringue pré-remplie
  • 5,700 IU per mL / per unit basis not statedinjectionFRAXIPARINE 5 700 U.I. Axa/0,6 ml, solution injectable (S.C.) en seringue pré-remplie
  • 3,800 IU per mL / per unit basis not statedinjectionFRAXIPARINE 3 800 U.I. Axa/0,4 ml, solution injectable (S.C.) en seringue pré-remplie
  • 2,850 IU per mL / per unit basis not statedinjectionFRAXIPARINE 2 850 U.I. Axa/0,3 ml, solution injectable (S.C.) en seringue pré-remplie

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.